跳至主要内容
临床试验/EUCTR2018-000283-28-NL
EUCTR2018-000283-28-NL进行中(未招募)1 期

Potential effect of proton-pump inhibitor on angiogenic markers in preeclampsia: a pilot study

未提供0 个研究点目标入组 44 人开始时间: 2018年5月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Women with (= 18 years) with a singleton pregnancy diagnosed with PE with a gestational age of =20 weeks and <34 weeks admitted to the obstetric department who give written informed consent, will be included.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 44
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Multiple pregnancies
  • Not willing to give written informed consent
  • Other reasons than PE requiring hospitalization
  • The use of PPI at time of randomization
  • Contraindications or hypersensitivity to PPI use
  • The use of medication affected by PPI
  • Fetal death at time of inclusion
  • Signs of fetal distress at time of inclusion
  • Expected delivery =2 days

研究者

发起方
未提供

相似试验